Track the TAKEDA PHARMACEUTICAL CO LTD share price and the full insider trade history of the company, a listed issuer based in United States. Shares are listed on the US market, under the oversight of SEC (Form 4). Market capitalisation: €55.6bn. The latest transaction was reported on 19 August 2026 (Notice of proposed sale (Form 144)). Among the most active insiders: Greenway Nicola Deidre Petal. All data is openly available.
53
Insider Decl.
n/a
Thresholds
n/a
n/a
Buy Volume
€9m
17 ops.
Sell Volume
48Σ signal
Buys n/a€9m Sells
This score ranks the purchase within its own market. No market currently meets the historical allocation criteria, so signals remain watch-only. Not investment advice.
Fundamental score
Ranked 10,187 of 29,024 companies
59.0
score / 100
Value
79
Quality
39
FCF yld·
Earn yld·
EV/EBITDA6.8x
ROE-2.3%
Gross mgn65%
Net mgn2.1%
Debt/EBITDA6.7x
Pillars2/3
Transparent value + quality ranking, distinct from the insider signal.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
Takeda Pharmaceutical Co Ltd is a Japanese pharmaceutical company focused on the research and development of innovative medicines. It specializes in therapeutic areas such as oncology, rare diseases, and gastrointestinal disorders.